Choose country site:
27 December 2016 - In March 2017, Ecorys will be presenting at DIA 1st BioVenture Day the study that has recently been conducted for the European Parliament.
Prior to The DIA 29TH annual euro meeting, the BioVenture Day will take place at Crowne Plaza Glasgow in United Kingdom. The meeting focuses on the question whether the current Bioventure paradigm is delivering return for patients, investors and the health care system. The congress meeting is intended, among others, for health care insurers, investment bankers, fund managers, business development heads, R&D leaders of biotech companies and big pharma.
Dr. Wija Oortwijn, lead researcher of the recent study for the EU Parliament “Links between pharmaceutical R&D Models and Access to Affordable Medicines’’ will present the challenges of access to affordable medicines taking into account the economic crisis, research & development of new medicines as well as pricing and reimbursement of medicines. Furthermore, she will provide information about the options available to ensure that European patients have equal access to affordable and adequate healthcare.
Click here for more information about the DIA event:
Click here for more information about the EP Study:
For more information, please contact:
Wija Oortwijn, Sector leader Health
T +31 (0)10 453 84 21 | E email@example.com